Shareholders of Applied Therapeutics Should Act Before February 2025 to Protect Their Interests

Crucial Alert for Applied Therapeutics Shareholders

Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT) are advised to take immediate action regarding their shares purchased between January 3, 2024, and December 2, 2024. According to a recent announcement by The Gross Law Firm, shareholders within this time frame may have the opportunity to discuss their rights and the possibility of appointing a lead plaintiff in an ongoing class action lawsuit.

Key Details of the Class Action

The class action pertains to significant concerns raised following the announcement of a Complete Response Letter (CRL) from the FDA regarding the company’s New Drug Application (NDA) for its primary drug candidate, govorestat. The release issued on November 27, 2024, noted that the FDA had completed its review and was unable to approve the NDA in its current form, citing notable deficiencies in the clinical application presented by the firm.

In the wake of this news, Applied Therapeutics saw a dramatic decline in its stock price. The stock fell from a closing price of $10.21 on November 26, 2024, to as low as $1.29 by December 5, 2024, marking a staggering decrease of over 80%. This swift drop was exacerbated further when the company disclosed a warning letter from the FDA after market hours on December 2, revealing grave issues with the clinical trials underlying the CRL.

Importance of Registering

Given the current situation, it is crucial for affected shareholders to contact The Gross Law Firm before the upcoming deadline of February 18, 2025. By registering, shareholders will not only gain insights into potential recovery options but will also be enrolled in a monitoring system that provides updates on the case's progression.

The Gross Law Firm is well-regarded for its commitment to protecting investor rights against deceit, fraud, and unethical business practices. They aim to ensure that companies operate under responsible business norms, helping investors who have suffered due to misleading information and stock inflation resulting from corporate non-compliance.

Steps to Take

1. Contact The Gross Law Firm: Shareholders who purchased shares of APLT during the established class period are encouraged to reach out to the firm for discussions regarding their rights and eligibility for recovery.
- Contact Information: 15 West 38th Street, 12th floor, New York, NY, 10018. Email: [email protected] Phone: (646) 453-8903.

2. Register for Monitoring: Upon registration, participants will have access to portfolio monitoring software that will keep them informed about the status of the case and their respective rights as shareholders.

3. Act Before Deadline: It is imperative not to delay. The window for taking action in this class action case closes on February 18, 2025, potentially limiting recovery options after this date.

In an environment where corporate accountability is vital, shareholders are encouraged to act swiftly to protect their investments and exercise their rights. Losses incurred from misleading corporate practices should be addressed decisively with the help of experienced legal professionals. The Gross Law Firm stands ready to assist those affected, ensuring that justice is pursued in the face of corporate malpractice.